Axi-cel demonstrated a 90% overall response rate and 75% complete response rate in relapsed/refractory indolent non-Hodgkin lymphoma. Median progression-free survival was 62.2 months, with a median ...

The progression of disease after first-line treatment reduces overall survival and increases all-cause mortality in patients with mantle cell lymphoma, a Swedish study reports.

The FDA has granted priority review to a new drug application (NDA) seeking the approval of sonrotoclax (BGB-11417; BeOne ...

A new international study found that radiation therapy did not affect 10-year survival rates for women with early-stage breast cancer who were considered “intermediate risk”. While radiation has been ...

Of the Arkansas businesses that started up in 2019, almost half of them, 49.4%, were still operating through 2024, according to data from the U.S. Bureau of Labor Statistics. There were 6,097 new ...

Donor type strongly influences survival, relapse risk, and GVHD after high-risk acute myeloid leukaemia stem cell transplantation.

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content ...

Exclusive: For anyone, having a loved one diagnosed with cancer is devastating. Especially when it's one of the least survivable kinds. But Steph McGuire, 31, lost her mother, father and aunt to the ...